Position in PEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,529,410
+$8,375,821 QoQ
Shares Held
25,975
+5158.1% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aquatic Capital Management LLC holds $72,444,028 across 22 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
985,535 | $42,062,633 | |
| 2 | ABT |
Abbott Laboratories
|
127,090 | $11,532,146 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
59,598 | $3,814,867 | |
| 4 | STE |
STERIS plc
|
16,627 | $3,501,147 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
32,655 | $2,811,268 | |
| 6 | PODD |
Insulet Corp
|
16,200 | $2,466,450 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
103,064 | $891,503 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
2,749 | $807,133 |
All Filings in PEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,529,410 | 25,975 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $153,589 | 494 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $303,080 | 1,181 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,514,610 | 5,664 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $1,835,694 | 10,200 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,914,270 | 26,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,112,936 | 8,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,954,000 | 32,880 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,399,516 | 18,600 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,031,153 | 3,700 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $66,639 | 300 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||